Medtronic | MDT - Selling And Administration Expenses


Medtronic reported 3.2B in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
AtriCure USD 82.88M 319K Sep/2026
Baxter International USD 730M 5M Sep/2026
Becton, Dickinson and Co. USD 1.26B 1000K Sep/2026
Boston Scientific USD 1.68B 120M Sep/2026
Cooper Companies USD 401.3M 274.9M Jun/2026
Danaher USD 2.16B 87M Sep/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 560.9M 300K Sep/2026
Globus Medical USD 288.47M 1.65M Sep/2026
Inogen USD 43.77M 510K Jun/2024
Insulet USD 350.7M 5.9M Sep/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
J&J USD 6.25B 168M Sep/2026
Medtronic 3.2B 141M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Philips EUR 1.17B 33M Sep/2026
Smith & Nephew USD 1.45B 29M Jun/2026
Stryker USD 2.12B 32M Jun/2026
Tandem Diabetes Care USD 113.94M 2.3M Sep/2026
Teleflex USD 220.72M 7.21M Sep/2026
Terumo JPY 109.58B 120M Sep/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Zimmer Biomet Holdings USD 855M 56.6M Sep/2026